Inventor · disambiguated record
David Pearson
Also filed as: PEARSON DAVID · PEARSON DAVID JAMES
12 granted patents·13 pending applications·55 citations·filing 2004–2025
89Inventor score
Top patents by PatentIndex Score
25 records- 0193US11773063B1Pharmaceutically acceptable salts and compositions thereofBECKLEY PSYTECH LTD·Filed 2022·Granted Oct 3, 2023·7 cites·10 claims
- 0293US11465969B2Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2019·Granted Oct 11, 2022·16 cites·32 claims
- 0392US11926592B2Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2022·Granted Mar 12, 2024·8 cites·21 claims
- 0486US10683300B2Polymorphic forms of Cyclo (-His-Pro)NOVMETAPHARMA CO LTD·Filed 2019·Granted Jun 16, 2020·5 cites·28 claims
- 0586US10336752B2TYK2 inhibitors, uses, and methods for production thereofNIMBUS LAKSHMI INC·Filed 2018·Granted Jul 2, 2019·5 cites·16 claims
- 0682US11040967B2TYK2 inhibitors, uses, and methods for production thereofNIMBUS LAKSHMI INC·Filed 2019·Granted Jun 22, 2021·3 cites·18 claims
- 0780US11820834B2Polymorphic forms of Cyclo (-His-Pro) and methods of use to treat kidney diseaseNOVMETAPHARMA CO LTD·Filed 2020·Granted Nov 21, 2023·1 cites·15 claims
- 0876US8536196B2Substituted 1,3-dioxanes useful as PPAR modulatorsSORENSEN ALEXANDRA SANTANA·Filed 2008·Granted Sep 17, 2013·4 cites·19 claims
- 0971US2024199550A1Salts and crystal forms of omecamtiv mecarbilAMGEN INC·Filed 2024·Application pending·0 cites
- 1069US12264131B2Pharmaceutically acceptable salts and compositions thereofBECKLEY PSYTECH LTD·Filed 2023·Granted Apr 1, 2025·0 cites·20 claims
- 1166US2025263372A1Pharmaceutically acceptable salts and compositions thereofBECKLEY PSYTECH LTD·Filed 2025·Application pending·0 cites
- 1264US2024317771A1Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compoundsNUVALENT INC·Filed 2024·Application pending·0 cites
- 1362US12043626B2Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compoundsNUVALENT INC·Filed 2022·Granted Jul 23, 2024·0 cites·36 claims
- 1462US2022306569A1Crystalline forms of hydroxynorketamineSMALL PHARMA LTD·Filed 2022·Application pending·0 cites
- 1560US2025339412A1Methods of treating solid tumor using (19r)-5-chloro-3-ethyl-16-fluoro-10,19-dimethyl-20-oxa-3,4,10,11,23-pentaazapentacyclo[19.3.1.02,6.08,12.013,18]pentacosa-1(24),2(6),4,8,11,13,15,17,21(25),22-decaen-22-amineNUVALENT INC·Filed 2023·Application pending·0 cites
- 1659US7516937B2Deformable molds and methods for their use in the manufacture of ophthalmic lensesJOHNSON & JOHNSON VISION CARE·Filed 2004·Granted Apr 14, 2009·6 cites·18 claims
- 1758US11377416B2Crystalline forms of hydroxynorketamineSMALL PHARMA LTD·Filed 2018·Granted Jul 5, 2022·0 cites·4 claims
- 1852US2024247026A1Salts and crystalline forms of (3e) 3-[o-[(phosphonooxy)methyl]oxime]-pregn-4-ene-3,20-dione and related usesNEUROTRAUMA SCIENCES LLC·Filed 2022·Application pending·0 cites
- 1952US2024190845A1Crystal forms of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1h-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-d3)pyridazine-3-carboxamideBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2050US2025222002A1Methods for treating benzodiazepine misuse/use disorderUNIV OF MISSISSIPPI MEDICAL CENTER·Filed 2025·Application pending·0 cites
- 2150US2023322797A1Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compoundsNUVALENT INC·Filed 2023·Application pending·0 cites
- 2245US2009146331A1Deformable molds and methods for their use in the manufacture of ophthalmic lensesHOFMANN GREGORY J·Filed 2009·Application pending·0 cites
- 2343US2021315840A1Solid oral dosage forms of ketamine derivativesSMALL PHARMA LTD·Filed 2018·Application pending·0 cites
- 2441US2020392084A1Sulfasalazine salt compositions and methods of using the sameABU IZZA KHAWLA·Filed 2018·Application pending·0 cites
- 2539US2010063065A1Thiophene derivatives as ppar agonists iINPHARMATICA LTD·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Pearson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →